With Organic Oxygen Containing Compound Patents (Class 514/164)
  • Patent number: 10369170
    Abstract: Provided herein are methods of treating basal cell carcinoma or glioblastoma by administering coal tar or a coal tar product to a patient with basal cell carcinoma or glioblastoma. The coal tar or coal tar product may be administered as a standalone therapy or in combination with other treatments for basal cell carcinoma or glioblastoma.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: August 6, 2019
    Inventor: Carol J. Buck
  • Patent number: 10201509
    Abstract: A composition for the treatment of acne includes hydrolyzed Psoralea Corylifolia, containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In a specific implementation, the composition is a water-based acne gel. In a specific implementation, a composition includes Bakutrol™, which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: February 12, 2019
    Assignee: Envy Medical, Inc.
    Inventors: Lyndon Garcines, Susan Goldsberry, Senad Ibrulj
  • Patent number: 9512166
    Abstract: Disclosed herein are cocrystals of progesterone and a coformer containing a six-membered aromatic ring having at least one substituent possessing a carbonyl functionality. Cocrystals of progesterone and a coformer selected from vanillic acid, benzoic acid, salicylic acid, cinnamic acid, or vanillin are also disclosed herein.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: December 6, 2016
    Assignee: AMRI SSCI, LLC
    Inventors: Ekaterina Albert, Patricia Andres, Melanie Janelle Bevill, Jared Smit, Jennifer Nelson
  • Publication number: 20150148320
    Abstract: Cosmetic compositions comprising salicylic acid derivatives and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The salicylic acid derivatives are believed to have modulatory activity against one or more biochemical pathways implicated in the appearance of human skin.
    Type: Application
    Filed: March 11, 2014
    Publication date: May 28, 2015
    Applicant: Avon Products, Inc.
    Inventors: Kai Xi, Sung Bin Shin, Hong Hu
  • Publication number: 20150119369
    Abstract: The present invention relates to compositions including anhydrous compositions which include a dimethicone crosspolymer and/or dimethicone elastomer gum and one or more skin care products.
    Type: Application
    Filed: October 29, 2014
    Publication date: April 30, 2015
    Inventors: James Jeffries Harrison, Nohemi Harrison
  • Patent number: 8987234
    Abstract: Disclosed are complexes of an antipneumocystic compound and an antimalarial compound, processes for their preparation, pharmaceutical compositions and methods of using said complexes or compositions for the treatment and/or prophylaxis of parasitic infections.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: March 24, 2015
    Assignee: IPCA Laboratories Ltd.
    Inventors: Ashok Kumar, Dharmendra Singh, Pramilkumar Mathur, Vitthal Syryabhan Buchude
  • Publication number: 20150072005
    Abstract: Provided are methods for enhancing the efficacy of aspirin. Also provided are methods for reducing pain or preventing or treating heart attack, stroke or blood clot in a subject in need thereof. The methods entail orally administering to the subject a first composition comprising a first amount of aspirin, and a second composition comprising a second amount of aspirin, wherein the first composition is formulated so as to, upon administration, disintegrate or dissolve intraorally providing rapid release of the aspirin of the first composition in the subject, and wherein the second composition is formulated to be substantially more difficult than the first composition to disintegrate or dissolve intraorally but is ingestible and releasable in the gastrointestinal track of the subject. The method can further include administering to the subject a painkiller or an agent suitable for treating a cardiovascular disease or condition.
    Type: Application
    Filed: September 10, 2013
    Publication date: March 12, 2015
    Inventor: Joseph P. Habboushe
  • Publication number: 20150038441
    Abstract: The invention relates to a kit-in-part comprising of a composition for the use as a cleaning and treating of ears of a companion animal and suitable packaging material, wherein the kit-in part additionally consists of components selected from the group of a pharmaceutical composition for use in the treatment of otitis externa, application and dosage information, cannules, cotton swabs, gauzes and information about the cleaning and maintenance ears of a companion animal.
    Type: Application
    Filed: December 21, 2011
    Publication date: February 5, 2015
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Joachim Karle, Reinhard Seffner
  • Publication number: 20150018319
    Abstract: The present invention is drawn to compositions, systems, and methods of treating skin disease. The composition includes a peroxygen, a transition metal or alloy thereof, and optionally, an alcohol and/or a drug. The composition can be packaged as part of a two-part system, and in one example, the drug is acetylsalicylic acid.
    Type: Application
    Filed: March 3, 2014
    Publication date: January 15, 2015
    Applicant: Solutions International, LLC
    Inventors: Brian G. Larson, David Larson
  • Publication number: 20140348957
    Abstract: The present invention is a compound comprising an NSAID portion and at least one of a progestin portion and a progesterone portion. The compound may take for instance the form of a pill or pellet (for oral internal use or for subdermal implantation), an injectable solution, or a suppository. The compound is intended for use in treating subjects having or being at increased risk—especially genetically determined risk—of developing endometriosis. The compound may also be used for treating other disorders or as a contraceptive.
    Type: Application
    Filed: May 19, 2014
    Publication date: November 27, 2014
    Inventor: Bradley C. Robinson
  • Patent number: 8889659
    Abstract: The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: November 18, 2014
    Assignee: API Genesis, LLC
    Inventors: Daniel Bucks, Philip J. Birbara
  • Patent number: 8883767
    Abstract: A low ether gel composition for application to skin comprising a keratolytic agent, in particular salicylic acid, and comprising a nitrocellulose and one or more volatile ingredients, which forms a film on contact with skin adequate to form a protective barrier for the keratolytic agent for a period of time necessary to provide treatment to the skin; methods of treating using such compositions, and dispensers containing such compositions.
    Type: Grant
    Filed: October 4, 2010
    Date of Patent: November 11, 2014
    Assignee: MSD Consumer Care, Inc.
    Inventors: Gerald R. Dever, Eric Chen-nan Su, William Scott Rogersr, Robert C. Johnson
  • Publication number: 20140328778
    Abstract: The present invention relates to the use of a 2,5-dihydroxybenzene derivative represented by Formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the therapeutic and/or prophylactic treatment of, inter alia, dermatitis.
    Type: Application
    Filed: July 17, 2014
    Publication date: November 6, 2014
    Inventors: Pedro Cuevas Sànchez, Guillermo Gimenez Gallego, Inigo Saenz de Tejada Gorman, Javier Angulo Frutos, Serafin Valverde Lopez, Antonio Romero Garrido, Rosa Maria Lozano Puerto
  • Publication number: 20140329782
    Abstract: The invention relates to a combined therapeutic agent, preferably for use at the prophylactic and/or therapeutic treatment of (A) in particular inflammatory diseases of the respiratory tract, in particular bronchopulmonary diseases, or of (B) in particular inflammatory diseases of the gastrointestinal tract, in particular of the intestine. The combined therapeutic agent comprises at least one vitamin D receptor agonist (VDA) and at least one further active substance, provided that the combined therapeutic agent does not contain any constituent and/or active substance from the group consisting of terpenes, monoterpenes, vasoconstrictors, alpha sympathomimetics and/or the physiologically harmless salts or derivatives thereof.
    Type: Application
    Filed: August 19, 2012
    Publication date: November 6, 2014
    Inventors: Anna Mai Joy Juergens, Heike Juergens, Lisa Joy Juergens
  • Patent number: 8846646
    Abstract: The invention relates to an unexpected discovery that propylene glycol is highly effective at killing or inhibiting Propionibacterium acnes in a mammalian skin disorder, as well as to the use of propylene glycol and salicylic acid in a skin-disorder treatment. This invention also relates to compositions containing propylene glycol alone or in combination with salicylic acid for use in killing or inhibiting Propionibacterium acnes.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: September 30, 2014
    Assignee: Winlind Skincare, LLC
    Inventor: Win L Chiou
  • Publication number: 20140274974
    Abstract: Disclosed is a preservative or antimicrobial system, and methods for its use, that includes at least one ester of salicylic acid and glycerin or a salt thereof.
    Type: Application
    Filed: March 11, 2014
    Publication date: September 18, 2014
    Applicant: Mary Kay Inc.
    Inventors: James Swanzy, Leslie Lockhart
  • Patent number: 8828977
    Abstract: The present invention provides a method for treating a vertebrate subject suffering from a degenerative disc disease by administering an inhibitor of a matrix metalloprotease (MMP) to the subject in an amount effective to treat the subject.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: September 9, 2014
    Assignee: Discogen, LLC
    Inventor: Peter A. Zahos
  • Publication number: 20140249116
    Abstract: A composition for the treatment of acne includes hydrolyzed Psoralea Corylifolia, containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In a specific implementation, the composition is a water-based acne gel. In a specific implementation, a composition includes Bakutrol™, which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.
    Type: Application
    Filed: March 1, 2013
    Publication date: September 4, 2014
    Applicant: ENVY MEDICAL, INC.
    Inventor: ENVY MEDICAL, INC.
  • Publication number: 20140235595
    Abstract: Disclosed herein are cocrystals of progesterone and a coformer containing a six-membered aromatic ring having at least one substituent possessing a carbonyl functionality. Cocrystals of progesterone and a coformer selected from vanillic acid, benzoic acid, salicylic acid, cinnamic acid, or vanillin are also disclosed herein.
    Type: Application
    Filed: September 4, 2013
    Publication date: August 21, 2014
    Applicant: Aptuit, Inc.
    Inventors: Ekaterina ALBERT, Patricia ANDRES, Melanie Janelle BEVILL, Jared SMIT, Jennifer NELSON
  • Publication number: 20140234420
    Abstract: The present invention describes methods and compositions for treating diverse dermatological conditions, including acne and psoriasis, using zein containing nanocarrier devices for topical delivery of methotrexate, retinoic acid and benzoyl peroxide to select targets in the skin.
    Type: Application
    Filed: August 14, 2013
    Publication date: August 21, 2014
    Inventors: Omathanu P. Perumal, Ranjith Kumar Averineni
  • Publication number: 20140213558
    Abstract: Embodiments of the invention relate generally to the treatment of inflammatory diseases and disorders and, more particularly, to the treatment of symptoms of inflammatory diseases and disorders using thymoquinone (TQ) alone or in combination with other compounds, including eicosapentaenoic acid (EPA). In one embodiment, the invention provides a pharmaceutical composition suitable for the treatment of at least one symptom of an inflammatory disease or disorder, comprising: an effective amount of thymoquinone; and at least one physiologically-acceptable carrier, wherein an effective amount of thymoquinone is an amount capable of reducing or preventing the at least one symptom of the inflammatory disease or disorder.
    Type: Application
    Filed: August 17, 2012
    Publication date: July 31, 2014
    Applicant: CREDE OILS (PTY) LTD
    Inventor: Philipp Crede
  • Publication number: 20140206654
    Abstract: The present invention refers to the use of a compound of Formula (I?) or pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of hematological dyscrasias, including myelodysplastic syndromes (MDSs) and for improving the efficacy of chemotherapy, radiation therapy and/or cancer immunotherapy. In addition, it relates to the use of a compound of formula (I?) for the treatment and/or prophylaxis of cancer of an organ.
    Type: Application
    Filed: August 12, 2013
    Publication date: July 24, 2014
    Applicant: Action Medicines, S.L.
    Inventors: Pedro Cuevas Sanchez, Guillermo Gimenez Gallego, Inigo Saenz De Tejada Morgan, Javier Angulo Frutos, Rosa Maria Lozano Puerto, Antonio Romero Garrido, Serafin Valverde Lopez
  • Publication number: 20140187518
    Abstract: Provided herein are sulfate free and/or sodium chloride free scalp treatment compositions comprising corticosteroid, combinations containing these compositions, kits and methods, particularly for treating and/or preventing itchy scalp.
    Type: Application
    Filed: March 15, 2013
    Publication date: July 3, 2014
    Inventors: Rebecca Kazin, Irwin A. Palefsky, Wanda Fontaine, Yamaris Melendez
  • Patent number: 8759325
    Abstract: Inflammatory bowel diseases are represented by two idiopathic disorders, which include ulcerative colitis and Crohn's disease. Ulcerative colitis is restricted to the colon and involves uncertain and inflammation of the lining (mucosa) of the large intestine. Crohn's disease, on the other hand, can involve the mucosa of the small and/or large intestine and may involve deeper layers of the bowel wall. The present invention is a combination of 5-aminosalicylic acid and one or more antioxidants (e.g., N-acetylcysteine) for treating such inflammatory bowel diseases.
    Type: Grant
    Filed: February 21, 2012
    Date of Patent: June 24, 2014
    Assignee: The Regents of the University of Oklahoma
    Inventor: Richard F. Harty
  • Publication number: 20140093587
    Abstract: The compositions and methods of this invention relate to peelable film-forming compositions that may be applied to and removed from the skin containing polyvinyl alcohols and adhesion-enhancing polymers.
    Type: Application
    Filed: September 28, 2012
    Publication date: April 3, 2014
    Inventors: Prashant Bahadur, Jeffrey M. Wu, Kamesh R. Yerramilli
  • Publication number: 20140037727
    Abstract: A medicament tablet containing paracetamol (acetaminophen) as the (or an) active ingredient, and an encapsulated flavorant. The tablet may be swallowed in tablet form or may be dissolved or dispersed in water to form a palatable drink.
    Type: Application
    Filed: October 8, 2013
    Publication date: February 6, 2014
    Applicant: Reckitt Benckiser Healthcare (UK) Limited
    Inventor: Paul Frederick Field
  • Patent number: 8629127
    Abstract: Inflammatory bowel diseases are represented by two idiopathic disorders, which include ulcerative colitis and Crohn's disease. Ulcerative colitis is restricted to the colon and involves uncertain and inflammation of the lining (mucosa) of the large intestine. Crohn's disease, on the other hand, can involve the mucosa of the small and/or large intestine and may involve deeper layers of the bowel wall. The present invention is a combination of 5-aminosalicylic acid and one or more antioxidants (e.g., N-acetylcysteine) for treating such inflammatory bowel diseases.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: January 14, 2014
    Assignee: The Regents of the University of Oklahoma
    Inventor: Richard F. Harty
  • Patent number: 8623847
    Abstract: Inflammatory bowel diseases are represented by two idiopathic disorders, which include ulcerative colitis and Crohn's disease. Ulcerative colitis is restricted to the colon and involves uncertain and inflammation of the lining (mucosa) of the large intestine. Crohn's disease, on the other hand, can involve the mucosa of the small and/or large intestine and may involve deeper layers of the bowel wall. The present invention is a combination of 5-aminosalicylic acid and one or more antioxidants (e.g., N-acetylcysteine) for treating such inflammatory bowel diseases.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: January 7, 2014
    Assignee: The Regents of the University of Oklahoma
    Inventor: Richard F. Harty
  • Publication number: 20130296282
    Abstract: The invention describes compositions and methods of use for 2,5-dihydroxybenzene sulfonic acid compounds and pharmaceutically acceptable salts thereof. The invention provides methods for (a) treating skin cancer; (b) treating cancer of the organs; (c) treating leukemia; (d) improving the efficacy of chemotherapy, radiation therapy and/or cancer immunotherapy; (e) treating rosacea; and (f) treating psoriasis by administration of a composition comprising at least one 2,5-dihydroxybenzene sulfonic acid compound or a pharmaceutically acceptable salt thereof, and, optionally at least one therapeutic agent. Also disclosed are compositions comprising administration of at least one 2,5-dihydroxybenzene sulfonic acid compound, or a pharmaceutically acceptable salt thereof, and, at least one therapeutic agent.
    Type: Application
    Filed: July 9, 2013
    Publication date: November 7, 2013
    Inventor: Pedro Cuevas Sànchez
  • Publication number: 20130287713
    Abstract: A shaving aid composition is provided that includes an organic polyhalogenic agent that both promotes post application foaming and increases lubricity. The shaving aid is optionally used to deliver one or more therapeutics to the skin of a subject and is therefore operable to prevent or treat a skin condition.
    Type: Application
    Filed: October 29, 2010
    Publication date: October 31, 2013
    Inventor: John E. Kulesza
  • Publication number: 20130280195
    Abstract: Compositions containing an effective dermatological disease-treating or dermatological condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle are disclosed. Methods of using the compositions are also disclosed.
    Type: Application
    Filed: June 17, 2013
    Publication date: October 24, 2013
    Inventor: Bryan B. Fuller
  • Publication number: 20130281411
    Abstract: Compositions are disclosed that contain an effective inflammatory-dermatological disease-treating or condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle. Methods of using the compositions to treat a subject's skin are also disclosed.
    Type: Application
    Filed: June 17, 2013
    Publication date: October 24, 2013
    Inventor: Bryan B. Fuller
  • Publication number: 20130274231
    Abstract: Compositions containing an effective dermatological disease-treating or dermatological condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle are disclosed.
    Type: Application
    Filed: June 17, 2013
    Publication date: October 17, 2013
    Inventor: Bryan B. Fuller
  • Publication number: 20130261093
    Abstract: A cosmetic composition in the form of an oil-in-water emulsion methods of using and producing cosmetic compositions is provided. The cosmetic composition includes an aqueous phase, an oil phase comprising a water-in-oil emulsifier, and an oil stabilizing component. The water-in-oil emulsifier is at concentration, by weight, of about 0.01% to about 6.0%, based upon weight of the composition. The oil stabilizing component includes one or both of an amphiphilic compound or a surfactant having an HLB of 13 or greater added to the aqueous phase. The oil stabilizing component is at a concentration, by weight, of about 0.01% to about 1.0%, based upon weight of the composition. The oil-in-water emulsion has an increased water load relative to water-in-oil emulsions without having an increased viscosity.
    Type: Application
    Filed: March 29, 2012
    Publication date: October 3, 2013
    Applicant: L'OREAL S.A.
    Inventors: Patricia BRIEVA, Angelike GALDI, Jean-Thierry SIMONNET, Anthony POTIN
  • Patent number: 8529920
    Abstract: A low pH composition containing a retinol and a method for treating skin is disclosed. The composition contains (a) a retinoid and (b) an active acid, like an alpha-hydroxy acid or a beta-hydroxy acid, and has a pH of less than 5.
    Type: Grant
    Filed: September 9, 2009
    Date of Patent: September 10, 2013
    Assignee: Amcol International Corporation
    Inventors: Limin Liu, Ralph Spindler, Gholam-Reza Vakili-Tahami
  • Publication number: 20130231310
    Abstract: The present invention relates to a mesalamine rectal suppository designed to provide improved comfort of use. One embodiment of the invention is a mesalamine rectal suppository-comprising mesalamine and one or more pharmaceutically acceptable excipients, wherein the drug load of the suppository ranges from 35% to 50%. Yet another embodiment of the invention is a mesalamine rectal suppository comprising mesalamine having a tap density ranging from about 600 to about 800 g/L (as measured by USP <616>) and a hard fat having an ascending melting point of 32 to 35.5° C. Yet another embodiment is a mesalamine rectal suppository comprising mesalamine particles and one or more pharmaceutically acceptable excipients, where the mesalamine particles have a surface area of from about 0.1 m2/g to about 2.8 m2/g (e.g., from about 0.1 m2/g to about 1.3 m2/g). Methods of preparing and methods of treatment with mesalamine suppositories are also provided.
    Type: Application
    Filed: April 10, 2013
    Publication date: September 5, 2013
    Applicant: Aptalis Pharma Canada Inc.
    Inventors: Carl GAUTHIER, Yves Dumoulin, David Powell, Hugues Moreau
  • Patent number: 8513281
    Abstract: A method for treating a patient/subject having neuronal injury, pain, neurotrauma and/or traumatic brain injury, such as diffuse axonal injury, which includes intrathecally and/or intraventricularly administering to the subject a therapeutically effective amount of a non-steroidal anti-inflammatory drug and/or a naturally occurring omega conotoxin, functional fragment thereof, a pharmacologically acceptable salt, ester, amide, or prodrug thereof.
    Type: Grant
    Filed: August 10, 2000
    Date of Patent: August 20, 2013
    Inventors: Jay M. Meythaler, Jean Peduzzi
  • Patent number: 8513225
    Abstract: Disclosed herein is a composition containing a high concentration of PG is unexpectedly capable of quickly killing other bacteria, fungi, and/or virus in vitro that is indicative of its potential high efficacy in treating various skin infection. Embodiments disclosed herein relate to a composition and method for effective topical treatment of inflammatory skin lesions in mammals, comprising of a high concentration of propylene glycol alone, or in combination with an astringent. The PG at high concentrations can be regarded as an extremely effective, safe, topical, universal, microbicide.
    Type: Grant
    Filed: April 5, 2011
    Date of Patent: August 20, 2013
    Assignee: Winlind Skincare, LLC
    Inventor: Win L Chiou
  • Publication number: 20130203711
    Abstract: The invention relates to a herbal oil, for controlling blood sugar without risk of hypoglycemia, comprising of the step of (i) fractional distillation of essential oils comprising of turpentine oil, jasmine oil, rose oil, eucalyptus oil, sandal wood oil and water green oil to obtain hydroxyl compounds #-terpinol, linalool, Gereneol, Citroneoll, #-Santalol, Methyl salicylate and other alcoholic terpenoils and (ii) dilution with fat oil so as to have approximate weight percentage of #-terpinol 50%, linalool 6%, Gereneol 4%, Citroneoll 3.5%, #-Santalol 2.7%, Methyl salicylate 2%, other alcoholic terpenoils and fat oil 31.8%.
    Type: Application
    Filed: October 4, 2011
    Publication date: August 8, 2013
    Inventor: Anil Kumar Gupta
  • Publication number: 20130196957
    Abstract: The present invention relates to an assembly (1) for packaging and application of a cosmetic and/or dermatological composition, comprising a container (2) having an opening (3), an applicator element (4), mounted in such a way as to be freely rotatable, in the vicinity of said opening (3), the applicator element (4) comprising an outer surface which can be brought into fluidic communication with the inside of the container (2), characterized in that the container (2) comprises a cosmetic and/or dermatological composition in the form of a gel having a viscosity at 25° C. of between 0.1 and 60 poises, and comprising, in a physiologically acceptable medium: (a) at least 1% by weight of salicylic acid and/or at least one derivative thereof, relative to the total weight of the composition; (b) at least one polyol; and (c) at least one gelling agent.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 1, 2013
    Applicant: L'OREAL
    Inventor: L'OREAL
  • Publication number: 20130157985
    Abstract: The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: September 10, 2012
    Publication date: June 20, 2013
    Applicant: API GENESIS, LLC
    Inventors: Daniel BUCKS, Philip J. BIRBARA
  • Publication number: 20130142882
    Abstract: The present invention provides methods and compositions for treating, preventing, modifying (reducing), or managing bone cancer pain by cyclohexenone compounds.
    Type: Application
    Filed: November 14, 2012
    Publication date: June 6, 2013
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventor: GOLDEN BIOTECHNOLOGY CORPORATION
  • Publication number: 20130065865
    Abstract: A long-lasting persistent, uniform film-forming skin protecting germicidal composition provides a long-lasting persistent barrier film when applied to skin. The compositions have particular utility as barrier teat dips for protecting cows against mastitis. A barrier film-forming agent is selected from the modified or hydrolyzed polysaccharides, particularly a hydrolyzed or modified starch, such as dextrin and maltodextrin. The barrier film-forming agent is stably solubilized in a solvent that dries to form the long-lasting persistent uniform film over the animal skin. The compositions also contain antimicrobial agents that fight against microbes that manage to penetrate the protective barrier film. Particularly, advantageous is that all the materials used are safe food additive and cost effective over the traditional barrier film forming agents.
    Type: Application
    Filed: March 7, 2012
    Publication date: March 14, 2013
    Applicant: DELAVAL HOLDING AB
    Inventors: Fahim U. Ahmed, N. Camelia Traistaru, Lieven Uytterhaegen
  • Publication number: 20130058880
    Abstract: Compositions, kits and methods of preparing a biocompatible film for cosmetic or medical uses are disclosed. The compositions or kits contain polyvinyl acetal (PVA), siloxane and a solvent. The siloxane can have a hydrophilic group. Once the solvent content is reduced, for instance, by evaporation, the mixture of PVA and siloxane is solidified, forming a film. The compositions and kits, optionally, further include one or more of an antimicrobial agent, a pigment, an anti-inflammatory agent, an anesthetic agent or a hemostatic agent. Such a film can be used, for example, in the form of an antimicrobial sealant, a liquid bandage, body paints, scar camouflage, water-proof sun block, makeup sealer, or antimicrobial wipe or spray.
    Type: Application
    Filed: May 9, 2011
    Publication date: March 7, 2013
    Inventor: Shaosheng Dong
  • Publication number: 20130029922
    Abstract: The invention provides novel compounds and formulations of turmeric oil, fish oil, aspirin and anti-cancer drugs (paclitaxel) having anti-inflammatory, analgesic and/or anti-cancer activity.
    Type: Application
    Filed: June 29, 2012
    Publication date: January 31, 2013
    Applicant: ORGANOMED CORPORATION
    Inventor: James N. Jacob
  • Publication number: 20120316140
    Abstract: A soluble aspirin composition, comprising: (i) granules including aspirin, heat-treated bicarbonate salt, pharmaceutically-acceptable resin and surfactant, in mixture with: (ii) crystalline particles of pharmaceutically-acceptable acid; and (iii) crystalline particles of heat-treated bicarbonate salt; wherein the soluble aspirin composition when introduced to water undergoes reaction of the crystalline particles of pharmaceutically-acceptable acid with the heat-treated bicarbonate salt and the aspirin to effect effervescing action and disintegration of the granules with conversion of the aspirin to an acetylsalicylate compound of the bicarbonate salt cation so that the composition rapidly dissolves in the water without occurrence of undissolved residue. The composition is solublizable within 30 seconds in cool to cold water to provide an effervescent analgesic solution that can be readily orally administered to an individual in need of analgesia.
    Type: Application
    Filed: June 13, 2011
    Publication date: December 13, 2012
    Applicant: PHARMSTAR PHARMACEUTICALS, INC.
    Inventor: Howard Phykitt
  • Publication number: 20120225100
    Abstract: A personal health care article. More particularly, a personal health care article comprising at least one porous disintegratable solid substrate comprising: from about 1% to about 70%, by weight of said substrate, of a surfactant, from about 10% to about 70%, by weight of said substrate, of one or more polymers, from about 0.025% to about 85%, by weight of said substrate, of one or more health care actives, optionally a plasticizer, and optionally an aesthetic agent wherein said article is ingestible. The invention also comprises a process for making a personal health care article.
    Type: Application
    Filed: March 1, 2012
    Publication date: September 6, 2012
    Inventors: Trevor John Darcy, Steven Ray Gilbert, Robert Wayne Glenn, JR., Mark Edward Stella
  • Publication number: 20120213717
    Abstract: In certain embodiments, the present invention is directed to the use of soothing agents to relieve mild irritation and/or enhance the overall soothing, comfort or refreshing feel of mucosal membranes of the eye, oral cavity, otic, nose, throat or vaginal area. The present invention further relates to compositions, articles and methods for masking or reducing the irritant properties of sensory compounds, such as terpenes and/or phenolic agents.
    Type: Application
    Filed: February 18, 2011
    Publication date: August 23, 2012
    Applicant: McNeil-PPC, Inc.
    Inventor: Mandar V. Shah
  • Publication number: 20120201769
    Abstract: Methods for treating excess pigmentation, including treatment of post inflammatory hyperpigmentation (PIH), are disclosed. The disclosed methods comprise administration of a composition comprising bakuchiol substantially free of furanocoumarins to a mammal. Compositions comprising bakuchiol and methods for their preparation are also disclosed.
    Type: Application
    Filed: February 2, 2012
    Publication date: August 9, 2012
    Applicant: Unigen, Inc.
    Inventors: Mei Feng Hong, Qi Jia, Lidia Alfaro Brownell
  • Publication number: 20120189684
    Abstract: This invention relates to skincare compositions, in particular compositions effective in the treatment of acne vulgaris, and to methods of treatment of the skin that involve the application of such compositions, wherein the compositions comprise salicylic acid or a salt thereof in combination with at 2 actives selected from the group consisting of lactic acid or a salt thereof; glycyrrhizinic acid or a salt or derivative thereof; bisabolol; cetylhydroxyproline palmitamide; allantoin; niacinamide; and epilobium angustifolium extract.
    Type: Application
    Filed: July 19, 2010
    Publication date: July 26, 2012
    Applicant: Reckitt Benckiser Healthcare International Limited
    Inventors: Carolyn Buckley, Stuart Jackson, Neil Kilcullen, Diane Marie Pavis